A new drug for the treatment of relapsed / refractory chronic lymphoblastic leukemia / small lymphocytic lymphoma: nemtabrutinib

doi:10.3969/j.issn.1672-3384.2023.12.002

TAO Fei, CHENG Mao-sheng, LIU Yang

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (12) : 7-10.

PDF(395 KB)

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (12) : 7-10. DOI: 10.3969/j.issn.1672-3384.2023.12.002

Comment of New Drug

A new drug for the treatment of relapsed / refractory chronic lymphoblastic leukemia / small lymphocytic lymphoma: nemtabrutinib

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 21(12): 7-10 https://doi.org/10.3969/j.issn.1672-3384.2023.12.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(395 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-10-11	2024-01-01
Issue Date
2024-01-01

Please choose a citation manager

Content to export